Small dense LDL-7 (sdLDL-7) is the smallest and densest LDL particle subfraction measured in comprehensive lipid testing. It represents the extreme end of LDL particle atherogenicity — these particles have the greatest capacity to cause arterial damage of any LDL subfraction.
Elevation of sdLDL-7 is a strong predictor of cardiovascular events and is particularly concerning in individuals who appear to have acceptable standard lipid results. Measurement of total small dense LDL (combining sdLDL-1 through 7) provides a single clinically actionable number that summarises the full atherogenic burden from this particle class, and its measurement is increasingly incorporated into advanced cardiovascular risk protocols.
FAQs
Is sdLDL-7 the most dangerous cholesterol particle?
sdLDL-7 is the smallest and densest LDL particle measured, making it the most atherogenic in the small dense LDL series. It has the greatest capacity for arterial penetration, oxidation, and resistance to clearance of any LDL subfraction.
Can sdLDL-7 be reduced to zero?
Not to zero, as some particle remodelling is normal. However, aggressive carbohydrate restriction, fibrates, and omega-3 fatty acids can dramatically reduce sdLDL-7 and the overall small dense LDL burden.
How does sdLDL-7 relate to total sdLDL?
Total sdLDL is the sum of all small dense LDL subfractions (sdLDL-1 through sdLDL-7) and provides a single integrated atherogenic particle count. sdLDL-7 contributes to this total as the highest-risk fraction.
Who most urgently needs sdLDL testing?
People with cardiovascular disease despite normal standard LDL, those with metabolic syndrome, severe insulin resistance, or very high triglycerides are most likely to have elevated sdLDL-7 and benefit most from subfraction analysis.
